Morpho Detection Awarded Frankfurt Airport Contract for Desktop Trace Detectors

HAMBURG, GERMANY -- Morpho (Safran), through its subsidiary Morpho Detection, today announced a contract with Fraport AG, the owner and manager of Frankfurt Airport, for 45 Itemiser® DX explosives trace detectors (ETD). Under terms of the contract, all systems will be deployed to Frankfurt Airport this year as a result of new EU legislation for [...]

Vivione Biosciences Inc. Announces Clinical Pilot with the Cleveland Clinic Department of Pathology

LITTLE ROCK, Ark.-- Vivione Biosciences Inc. (“Vivione”) (TSX:VBI), through its wholly owned subsidiary, Vivione Biosciences, LLC, is pleased to announce that it will begin a clinical pilot evaluation of its RAPID-B platform at the prestigious Cleveland Clinic Department of Pathology. “We’re excited about the opportunity to work with Dr. Gary Procop on the clinical pilot [...]

Bio-Techne Announces Agreement To Acquire CyVek

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) announced today that it has agreed to acquire CyVek, Inc. (CyVek) for $60 million in cash, plus a potential earn-out payment of up to $35 million based on CyVek revenue over the 30-month period following the closing and an additional potential earn-out payment based on CyVek revenue through 2020 [...]

Complete Microbial Detection Beads Bring New Meaning to ‘Master Mix’

CARLSBAD, Calif. -- Food and environmental scientists can reduce delays caused by messy preparation and problematic inhibitors with a new master mix designed to offer fast and accurate DNA detection. The new TaqMan Fast Environmental Master Mix Beads give scientists a freeze-dried PCR enzyme formulation optimized for enhanced real-time PCR performance and improved convenience. Designed [...]

NEW STARTUP ‘BIO DATA BRIDGES’ OFFERS LAB DATA MANAGEMENT HEALTH CHECK™

SEATTLE, WA -- The challenge of future-proofing scientific data systems just got a lot easier for life science companies. The Lab Data Management Health Check?, a free initial consultation, provides a map for improvements to scientific data management. This is good news for researchers and their IT managers who need to support the growth of [...]

ZEISS Presents World’s Fastest Scanning Electron Microscope

JENA/Germany, WASHINGTON D.C./USA -- At the annual Neuroscience meeting in Washington, D.C., November 15-19, 2014, ZEISS will present ZEISS MultiSEM 505, its new scanning electron microscope (SEM). As the first SEM in the world, the system features 61 beams working in parallel, and offers an unrivaled capture speed of 1220 megapixels per second at a [...]

Global Stem Cells Group Named Exclusive Distributor for Adistem and Adilyfe Companies and Product Lines

MIAMI -- Global Stem Cells Group, Inc. has been named exclusive distributor for Adistem medical solutions, and Adilyfe, a new regenerative medicine products company founded by Adistem Ltd. Scientific Founder Vasilis Paspaliaris, M.D. in Melbourne, Australia and set to launch in early 2015. Paspaliaris made the announcement at the First International Symposium on Stem Cells [...]

Sigma-Aldrich Completes Acquisition of Cell Marque

ST. LOUIS -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, announced it has completed its acquisition of Rocklin, California based Cell Marque Corporation, an industry-leading provider of in vitro diagnostic (IVD) antibody reagents and kits. The Company expects this acquisition to be neutral to mildly accretive to earnings per share [...]

Purdue-based startup measures movement in cells to improve cancer drug development

WEST LAFAYETTE, Ind. - Officials at a life sciences startup based on a Purdue University innovation say their technology could help pharmaceutical companies find more effective drug candidates and improve the results of personalized cancer care. David Nolte, president of Animated Dynamics Inc., said pharmaceutical companies screen millions of compounds annually to find new drug [...]

FDA Clears ISCO’s Stem Cell Line for Clinical Uses

CARLSBAD, CA -- International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today announced that the U. S. Food and Drug Administration (FDA) has cleared ISCO's human parthenogenetic stem cells line for investigational clinical use. "Many stem cell lines can never be used to develop [...]

Access IBO on Knowledge Center